Blood 2018 Apr 19
A phase 1 study of ibrutinib in combination with R-ICE in patients with relapsed or primary refractory DLBCL.
Related Questions
There are multiple options that carry a category 2B recommendation in the NCCN guidelines. Does germinal B center type vs activated B-cell type play a...
New answer by Medical Oncologist at Genentech (January 2, 2020)
Outside the context of a clinical trial, I typically use RICE or RDHAX for transplant eligible relapsed/refractory DLBCL. BioCORAL gave a signal that GCB like DLBCL may have b...